Scientific Sessions 2025  /  Featured Science in EP  /  Discussant
Logo

American Heart Association

  27
  0

Final ID:

Discussant

  • Calkins, Hugh  ( JOHNS HOPKINS UNIVERSITY SCHOOL MED , Baltimore , Maryland , United States )
  • Lampert, Rachel  ( YALE SCH OF MEDICINE , New Haven , Connecticut , United States )
  • Ackerman, Michael  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Sun, Albert  ( Duke University Medical Center , Durham , North Carolina , United States )
  • Daubert, James  ( Duke University , Chapel Hill , North Carolina , United States )
    • Author Disclosures:
    Hugh Calkins: DO NOT have relevant financial relationships | Rachel Lampert: DO NOT have relevant financial relationships | Michael Ackerman: DO have relevant financial relationships ; Consultant:Abbott:Active (exists now) ; Royalties/Patent Beneficiary:UpToDate:Active (exists now) ; Royalties/Patent Beneficiary:Thryv Therapeutics:Active (exists now) ; Royalties/Patent Beneficiary:Solid Biosciences:Active (exists now) ; Royalties/Patent Beneficiary:Prolaio:Active (exists now) ; Royalties/Patent Beneficiary:ARMGO Pharma:Active (exists now) ; Royalties/Patent Beneficiary:AliveCor:Active (exists now) ; Consultant:Tenaya Therapeutics:Active (exists now) ; Consultant:Medtronic:Active (exists now) ; Consultant:Invitae:Past (completed) ; Consultant:Illumina:Active (exists now) ; Consultant:Bristol Myers Squibb:Past (completed) ; Consultant:Boston Scientific:Active (exists now) ; Consultant:BioMarin Pharmaceutical:Past (completed) | Albert Sun: No Answer | James Daubert: DO have relevant financial relationships ; Royalties/Patent Beneficiary:Wiley - book Editor:Active (exists now) ; Advisor:Boston Scientific -Steering Committee.:Active (exists now) ; Independent Contractor:Synaptic Medical Corporation - CEC:Active (exists now) ; Independent Contractor:Biosense -CEC:Active (exists now) ; Independent Contractor:NHLBI /URMC -DSMB:Active (exists now) ; Independent Contractor:Cordis -CEC:Past (completed) ; Independent Contractor:Affera -CEC:Past (completed) ; Independent Contractor:Acutus -CEC/Safety Officer:Past (completed) ; Consultant:Livanova / Microport CRM:Past (completed) ; Consultant:Biotronik:Past (completed) ; Consultant:Medtronic - :Active (exists now) ; Research Funding (PI or named investigator):Carrion --funding to Duke:Active (exists now) ; Research Funding (PI or named investigator):Rocket Pharm. -funding to Duke:Active (exists now) ; Royalties/Patent Beneficiary:Springboard -education content:Active (exists now) ; Royalties/Patent Beneficiary:McGraw Hill -book author:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Featured Science in EP

Monday, 11/10/2025 , 08:00AM - 09:15AM

Featured Science

More abstracts on this topic:
Efficacy and safety of flecainide compared to amiodarone for atrial fibrillation cardioversion in patients with Coronary Artery Disease and preserved ejection fraction. FLECA-ED trial

Tsioufis Panagiotis-anastasios, Patsilinakos Sotirios, Kafkas Nikos, Tsioufis Konstantinos, Tsiachris Dimitris, Argyriou Nikolaos, Botis Michail, Kordalis Athanasios, Doundoulakis Ioannis, Antoniou Christos-konstantinos, Matthaiopoulos George, Zamanis Ioannis

Primary Results from the Post Approval Study of a Next Generation Wearable Cardioverter Defibrillator System: the ACE-PAS Trial

Poole Jeanne, Gleva Marye, Branch Kelley, Birgersdotter-green Ulrika, Doshi Rahul, Mahankali Sridhar Arun Raghav, Wang Melinda, Gustavson Laura, Zulueta Shirley

More abstracts from these authors:
Is it safe for my patient with genetic cardiomyopathy to exercise?

Lampert Rachel, Ackerman Michael, Saberi Sara, Day Sharlene

When can I provide sports clearance for my patient with inherited arrhythmia?

Lampert Rachel, Kim Jonathan

You have to be authorized to contact abstract author. Please, Login
Not Available